Related Experiment Video
Updated: Aug 29, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
Patent foramen ovale and stroke
Steven C Horton1, T Jared Bunch
1Department of Cardiology, Department of Internal Medicine, LDS Hospital and University of Utah School of Medicine, Salt Lake City, USA. SCHorton@msn.com
Abstract:
A patent foramen ovale (PFO) is a frequent remnant of embryological development with clinical importance in thromboembolism, paradoxical embolism, stroke, platypnea-orthodeoxia, decompression sickness, and migraine headache. The proposed mechanisms of stroke with PFO include paradoxical embolization, in situ thrombosis within the canal of the PFO, associated atrial arrhythmias, and concomitant hypercoagulable states. Prospective trials using aspirin treatment to reduce recurrent stroke showed a significant recurrence of neurologic events in patients with a PFO and atrial septal aneurysm. Use of warfarin anticoagulation does not further reduce recurrent stroke rates compared with antiplatelet therapy. Both surgical and catheter-based modes of closure have been shown to decrease the rate of subsequent embolic events substantially. Successful closure, defined by transesophageal echocardiography, appears to predict freedom from subsequent embolic events. To our knowledge, no randomized trials comparing anticoagulation with surgical or catheter-based closure have been performed.
Insights
Patent foramen ovale (PFO) closure significantly reduces embolic events. Medical treatments like aspirin or warfarin show limited benefit for stroke recurrence in PFO patients, especially with atrial septal aneurysm.
Area of Science:
- Cardiology
- Neurology
- Embryology
Background:
- Patent foramen ovale (PFO) is a common congenital heart defect with significant clinical implications.
- PFO is linked to stroke, paradoxical embolism, and other serious conditions.
- Mechanisms for stroke in PFO patients include paradoxical embolization and associated arrhythmias.
Purpose of the Study:
- To review the clinical significance of PFO.
- To evaluate treatment strategies for stroke prevention in PFO patients.
- To assess the efficacy of PFO closure versus medical management.
Main Methods:
- Review of prospective trials and existing literature on PFO.
- Analysis of treatment outcomes for aspirin, warfarin, and PFO closure (surgical and catheter-based).
- Assessment of successful closure criteria using transesophageal echocardiography.
Main Results:
- Aspirin treatment did not prevent recurrent stroke in PFO patients with atrial septal aneurysm.
- Warfarin did not offer additional benefit over antiplatelet therapy for stroke recurrence.
- Both surgical and catheter-based PFO closure substantially decreased subsequent embolic events.
Conclusions:
- PFO closure is effective in reducing embolic events.
- Medical management alone is less effective for stroke prevention in specific PFO populations.
- Further randomized trials are needed to compare anticoagulation with closure methods.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
